208 related articles for article (PubMed ID: 18508119)
1. Dissociation of the anxiolytic-like effects of Avpr1a and Avpr1b receptor antagonists in the dorsal and ventral hippocampus.
Engin E; Treit D
Neuropeptides; 2008 Aug; 42(4):411-21. PubMed ID: 18508119
[TBL] [Abstract][Full Text] [Related]
2. Α2 GABAA receptor sub-units in the ventral hippocampus and α5 GABAA receptor sub-units in the dorsal hippocampus mediate anxiety and fear memory.
McEown K; Treit D
Neuroscience; 2013 Nov; 252():169-77. PubMed ID: 23962649
[TBL] [Abstract][Full Text] [Related]
3. Mineralocorticoid receptors in the medial prefrontal cortex and hippocampus mediate rats' unconditioned fear behaviour.
McEown K; Treit D
Horm Behav; 2011 Nov; 60(5):581-8. PubMed ID: 21889941
[TBL] [Abstract][Full Text] [Related]
4. The septum and the hippocampus differentially mediate anxiolytic effects of R(+)-8-OH-DPAT.
Menard J; Treit D
Behav Pharmacol; 1998 Mar; 9(2):93-101. PubMed ID: 10065929
[TBL] [Abstract][Full Text] [Related]
5. Distinct ventral and dorsal hippocampus AP5 anxiolytic effects revealed in the elevated plus-maze task in rats.
Nascimento Häckl LP; Carobrez AP
Neurobiol Learn Mem; 2007 Sep; 88(2):177-85. PubMed ID: 17540583
[TBL] [Abstract][Full Text] [Related]
6. The anxiolytic-like effects of allopregnanolone vary as a function of intracerebral microinfusion site: the amygdala, medial prefrontal cortex, or hippocampus.
Engin E; Treit D
Behav Pharmacol; 2007 Sep; 18(5-6):461-70. PubMed ID: 17762514
[TBL] [Abstract][Full Text] [Related]
7. Vasopressin stimulates insulin release from islet cells through V1b receptors: a combined pharmacological/knockout approach.
Oshikawa S; Tanoue A; Koshimizu TA; Kitagawa Y; Tsujimoto G
Mol Pharmacol; 2004 Mar; 65(3):623-9. PubMed ID: 14978240
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of anxiety-related behaviour after the antagonism of transient receptor potential vanilloid type 1 channels in the rat ventral hippocampus.
Santos CJ; Stern CA; Bertoglio LJ
Behav Pharmacol; 2008 Jul; 19(4):357-60. PubMed ID: 18622185
[TBL] [Abstract][Full Text] [Related]
9. Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats.
Knoll AT; Meloni EG; Thomas JB; Carroll FI; Carlezon WA
J Pharmacol Exp Ther; 2007 Dec; 323(3):838-45. PubMed ID: 17823306
[TBL] [Abstract][Full Text] [Related]
10. Characterization of (2S,4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonist.
Serradeil-Le Gal C; Wagnon J; Simiand J; Griebel G; Lacour C; Guillon G; Barberis C; Brossard G; Soubrié P; Nisato D; Pascal M; Pruss R; Scatton B; Maffrand JP; Le Fur G
J Pharmacol Exp Ther; 2002 Mar; 300(3):1122-30. PubMed ID: 11861823
[TBL] [Abstract][Full Text] [Related]
11. Involvement of opioidergic system of the ventral hippocampus, the nucleus accumbens or the central amygdala in anxiety-related behavior.
Zarrindast MR; Babapoor-Farrokhran S; Babapoor-Farrokhran S; Rezayof A
Life Sci; 2008 Jun; 82(23-24):1175-81. PubMed ID: 18456284
[TBL] [Abstract][Full Text] [Related]
12. The role of the dorsal and ventral hippocampus in fear and memory of a shock-probe experience.
McEown K; Treit D
Brain Res; 2009 Jan; 1251():185-94. PubMed ID: 19061870
[TBL] [Abstract][Full Text] [Related]
13. Differences in intermale aggression are accompanied by opposite vasopressin release patterns within the septum in rats bred for low and high anxiety.
Beiderbeck DI; Neumann ID; Veenema AH
Eur J Neurosci; 2007 Dec; 26(12):3597-605. PubMed ID: 18052969
[TBL] [Abstract][Full Text] [Related]
14. Anxiolytic-like effects of substance P administration into the dorsal, but not ventral, hippocampus and its influence on serotonin.
Carvalho MC; Masson S; Brandão ML; de Souza Silva MA
Peptides; 2008 Jul; 29(7):1191-200. PubMed ID: 18490080
[TBL] [Abstract][Full Text] [Related]
15. Noradrenergic facilitation of shock-probe defensive burying in lateral septum of rats, and modulation by chronic treatment with desipramine.
Bondi CO; Barrera G; Lapiz MD; Bedard T; Mahan A; Morilak DA
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):482-95. PubMed ID: 17188790
[TBL] [Abstract][Full Text] [Related]
16. Modulation of anxiety behavior in the elevated plus maze using peptidic oxytocin and vasopressin receptor ligands in the rat.
Mak P; Broussard C; Vacy K; Broadbear JH
J Psychopharmacol; 2012 Apr; 26(4):532-42. PubMed ID: 21890582
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological effects of the metabotropic glutamate receptor 1 antagonist compared with those of the metabotropic glutamate receptor 5 antagonist and metabotropic glutamate receptor 2/3 agonist in rodents: detailed investigations with a selective allosteric metabotropic glutamate receptor 1 antagonist, FTIDC [4-[1-(2-fluoropyridine-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide].
Satow A; Maehara S; Ise S; Hikichi H; Fukushima M; Suzuki G; Kimura T; Tanak T; Ito S; Kawamoto H; Ohta H
J Pharmacol Exp Ther; 2008 Aug; 326(2):577-86. PubMed ID: 18487514
[TBL] [Abstract][Full Text] [Related]
18. Anxiogenic-like effects of mCPP microinfusions into the amygdala (but not dorsal or ventral hippocampus) in mice exposed to elevated plus-maze.
Cornélio AM; Nunes-de-Souza RL
Behav Brain Res; 2007 Mar; 178(1):82-9. PubMed ID: 17207863
[TBL] [Abstract][Full Text] [Related]
19. The effects of histaminergic agents in the ventral hippocampus of rats in the plus-maze test of anxiety-like behaviours.
Rostami P; Hajizadeh-Moghaddam A; Zarrindast MR
Physiol Behav; 2006 May; 87(5):891-6. PubMed ID: 16600315
[TBL] [Abstract][Full Text] [Related]
20. Selective antagonism of medial prefrontal cortex D4 receptors decreases fear-related behaviour in rats.
Shah AA; Sjovold T; Treit D
Eur J Neurosci; 2004 Jun; 19(12):3393-7. PubMed ID: 15217397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
